indazoles has been researched along with n-((3s)-1-azabicyclo(2.2.2)oct-3-yl)-1h-indazole-3-carboxamide hydrochloride in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertrand, D; Callahan, PM; Graham, E; Herbert, B; Lowe, DA; Murray, M; Ong, V; Porter, R; Rodefer, JS; Rowe, WB; Santarelli, L; Tehim, A; Terry, AV; Tombaugh, G; Wallace, TL; Wang, S; Xie, W | 1 |
| Felix, AR; Huang, M; Kwon, S; Lowe, D; Meltzer, HY; Santarelli, L; Wallace, T | 1 |
| Garibaldi, G; Keefe, RS; Lowe, DA; Murray, S; Porter, R; Santarelli, L; Umbricht, D | 1 |
| Hao, Y; Tang, J; Wang, K | 1 |
| Dong, EZ; Jennings, G; Kuang, S; Pierce, M; Zhang, P; Zhao, B | 1 |
| Bassett, S; Boess, F; Funk, J; Lenz, B; Niederhauser, U; Roth, AB; Singer, T; Zhang, JD | 1 |
1 trial(s) available for indazoles and n-((3s)-1-azabicyclo(2.2.2)oct-3-yl)-1h-indazole-3-carboxamide hydrochloride
| Article | Year |
|---|---|
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Bridged Bicyclo Compounds; Cognition Disorders; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for indazoles and n-((3s)-1-azabicyclo(2.2.2)oct-3-yl)-1h-indazole-3-carboxamide hydrochloride
| Article | Year |
|---|---|
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Binding, Competitive; Bridged Bicyclo Compounds; Cell Line, Tumor; Cognition; Drug Partial Agonism; Female; Humans; Indazoles; Male; Nicotinic Agonists; Rats; Rats, Inbred F344; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Sensory Gating; Xenopus laevis | 2011 |
The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Bridged Bicyclo Compounds; Cerebral Cortex; Dopamine; Hippocampus; Indazoles; Male; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists | 2014 |
Development of Automated Patch Clamp Assay for Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists in Automated QPatch-16.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Automation; Bridged Bicyclo Compounds; Humans; Indazoles; Isoxazoles; Nicotinic Agonists; Patch-Clamp Techniques; Phenylurea Compounds; Quinuclidines; Rats; Thiophenes; Tumor Cells, Cultured | 2015 |
Crystal form control and particle size control of RG3487, a nicotinic α7 receptor partial agonist.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Bridged Bicyclo Compounds; Chemistry, Pharmaceutical; Crystallization; Drug Partial Agonism; Indazoles; Molecular Structure; Particle Size; Thermodynamics | 2016 |
Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitro.
Topics: Animals; Biomarkers; Bridged Bicyclo Compounds; Carcinogens; Cells, Cultured; DNA Replication; Dogs; Gene Expression Regulation; Hepatocytes; Humans; Indazoles; Male; Mice; Phenotype; Rats; Species Specificity | 2017 |